The Securities and Exchange Commission (SEC) has obtained a final judgment against stock promoter Carl Smith for misrepresentations he made to investors while raising funds for Nanobeak Biotech Inc.
The judgment was issued by the U.S. District Court for the Southern District of New York earlier in January.
According to the SEC’s complaint, filed on December 9, 2020, between at least December 2015 and December 2019, Nanobeak Biotech Inc. and its former CEO, Jeremy Barbera, solicited and sold Nanobeak securities using false and misleading statements. During this period, Nanobeak and Barbera, with the help of Smith, sold securities to at least 37 investors, raising a total of approximately $3.6 million.
Smith consented to the entry of a final judgment permanently enjoining him from violating Section 17(a) of the Securities Act of 1933 and Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder. The final judgment also ordered Smith to pay a civil money penalty of $100,000, and ordered disgorgement of $173,875, plus $23,470.59 in prejudgment interest.#sec#
免責事項：本記事で述べられている見解は著者の見解のみであり、Followmeの公式見解を反映するものではありません。Followmeは、提供された情報の正確性、完全性、信頼性について一切責任を負いません。また、書面で明示的に記載されている場合を除き、本記事の内容に基づいて行われたいかなる行動についても責任を負いません。
古いコメントはありません。ソファをつかむ最初のものになりましょう。